CIPHER PHARMACEUTICALS INC (CPH.CA) Stock Analyst Earnings Estimates
TSX:CPH - Toronto Stock Exchange - CA17253X1050 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20.68M -5.74% | 21.162M 2.33% | 33.363M 57.66% | 51.825M 55.34% | 57.638M 11.22% | 61.653M 6.97% | |
| EBITDA YoY % growth | 12.04M -12.50% | 11.26M -6.48% | 11.865M 5.37% | 25.367M 113.80% | 27.681M 9.12% | 29.314M 5.90% | |
| EBIT YoY % growth | 11.05M -15.39% | 10.033M -9.20% | 7.848M -21.78% | 17.169M 118.77% | 22.126M 28.87% | N/A | |
| Operating Margin | 53.43% | 47.41% | 23.52% | 33.13% | 38.39% | N/A | |
| EPS YoY % growth | N/A 14.03% | 0.79 123.48% | 0.45 -43.04% | 0.63 40.28% | 0.73 15.73% | 0.71 -3.23% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.16 34.67% | 0.15 1,415.00% | 0.20 102.00% | 0.21 31.25% | 0.21 40.00% | 0.21 |
| Revenue Q2Q % growth | 13.057M 146.17% | 13.401M 29.23% | 13.196M 9.79% | 13.587M 4.06% | 13.724M 2.41% | 13.922M |
| EBITDA Q2Q % growth | 6.476M 104.29% | 6.606M 50.96% | 6.537M 52.16% | 6.75M 4.23% | 6.796M 2.88% | 6.927M |
| EBIT Q2Q % growth | 4.953M 91.31% | 6.149M 228.82% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.10 -50.00% | 0.11 | -0.01 | -7.18% |
| Q4 2024 Q2Q % growth | 0.13 -56.67% | 0.21 | -0.08 | -37.21% |
| Q3 2024 Q2Q % growth | 0.01 -96.30% | 0.19 | -0.18 | -94.79% |
| Q2 2024 Q2Q % growth | 0.12 | 0.12 | 0.00 | 1.84% |
| Q1 2024 Q2Q % growth | 0.20 100.00% | 0.10 | 0.10 | 98.02% |
| Q4 2023 Q2Q % growth | 0.30 -61.04% | 0.10 | 0.20 | 212.66% |
| Q3 2023 Q2Q % growth | 0.27 170.00% | 0.07 | 0.20 | 281.90% |
| Q2 2023 Q2Q % growth | 0.12 -8.61% | 0.09 | 0.03 | 32.01% |
| Q1 2023 Q2Q % growth | 0.10 -17.49% | 0.08 | 0.02 | 23.76% |
| Q4 2022 Q2Q % growth | 0.77 600.00% | 0.09 | 0.68 | 747.08% |
| Q3 2022 Q2Q % growth | 0.10 100.00% | 0.09 | 0.01 | 10.01% |
| Q2 2022 Q2Q % growth | 31.30% | 0.13 | % | |
| Q1 2022 Q2Q % growth | 142.40% | 0.12 | % | |
| Q4 2021 Q2Q % growth | 0.11 | 0.11 | 0.00 | -0.99% |
| Q3 2021 Q2Q % growth | 0.05 -16.67% | 0.09 | -0.04 | -44.99% |
| Q2 2021 Q2Q % growth | 0.10 400.00% | 0.08 | 0.02 | 23.76% |
| Q1 2021 Q2Q % growth | 0.05 -44.44% | -0.09 | 0.14 | 155.01% |
| Q4 2020 Q2Q % growth | 0.00 -100.00% | 0.07 | -0.07 | -100.00% |
| Q3 2020 Q2Q % growth | 0.06 20.00% | % | ||
| Q2 2020 Q2Q % growth | 0.02 -71.43% | 0.07 | -0.05 | -69.54% |
| Q1 2020 Q2Q % growth | 0.09 200.00% | 0.06 | 0.03 | 48.51% |
| Q4 2019 Q2Q % growth | 0.10 | 0.05 | 0.05 | 120.02% |
| Q3 2019 Q2Q % growth | 0.05 | 0.04 | 0.01 | 41.44% |
| Q2 2019 Q2Q % growth | 0.07 | 0.03 | 0.04 | 131.02% |
| Q1 2019 Q2Q % growth | 0.03 | 0.02 | 0.01 | 48.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 12.019M 104.86% | 12.101M | -82K | -0.68% |
| Q4 2024 Q2Q % growth | 11.822M 140.28% | 11.884M | -62K | -0.52% |
| Q3 2024 Q2Q % growth | 10.37M 70.90% | 9.708M | 662K | 6.82% |
| Q2 2024 Q2Q % growth | 5.304M 0.30% | 5.452M | -148K | -2.71% |
| Q1 2024 Q2Q % growth | 5.867M 20.08% | 5.089M | 778K | 15.29% |
| Q4 2023 Q2Q % growth | 4.92M 0.20% | 5.286M | -366K | -6.92% |
| Q3 2023 Q2Q % growth | 6.068M 26.68% | 4.079M | 1.989M | 48.76% |
| Q2 2023 Q2Q % growth | 5.288M -4.89% | 5.418M | -130K | -2.40% |
| Q1 2023 Q2Q % growth | 4.886M -9.85% | 5.595M | -709K | -12.67% |
| Q4 2022 Q2Q % growth | 4.91M -16.07% | 5.715M | -805K | -14.09% |
| Q3 2022 Q2Q % growth | 4.79M 6.21% | 5.803M | -1.013M | -17.46% |
| Q2 2022 Q2Q % growth | 5.56M -9.30% | 6.143M | -582.779K | -9.49% |
| Q1 2022 Q2Q % growth | 5.42M -0.55% | 5.848M | -428.429K | -7.33% |
| Q4 2021 Q2Q % growth | 5.85M -4.88% | 6.04M | -190K | -3.15% |
| Q3 2021 Q2Q % growth | 4.51M -7.01% | 5.942M | -1.432M | -24.10% |
| Q2 2021 Q2Q % growth | 6.13M 30.15% | 5.374M | 756K | 14.07% |
| Q1 2021 Q2Q % growth | 5.45M -7.63% | 5.25M | 200K | 3.81% |
| Q4 2020 Q2Q % growth | 6.15M 4.06% | 4.78M | 1.37M | 28.66% |
| Q3 2020 Q2Q % growth | 4.85M -16.38% | 5.555M | -705K | -12.69% |
| Q2 2020 Q2Q % growth | 4.71M -15.89% | 5.111M | -401K | -7.85% |
| Q1 2020 Q2Q % growth | 5.9M 14.79% | 5.007M | 893K | 17.84% |
| Q4 2019 Q2Q % growth | 5.91M | 5.247M | 663K | 12.64% |
| Q3 2019 Q2Q % growth | 5.8M | 5.254M | 546K | 10.39% |
| Q2 2019 Q2Q % growth | 5.6M | 5.757M | -157K | -2.73% |
| Q1 2019 Q2Q % growth | 5.14M | 5.656M | -516K | -9.12% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.03% | 0% | 0% |
| Revenue | 0% | 1.52% | 1.35% | 1.35% |